142 related articles for article (PubMed ID: 38324102)
1. The Role of Complement Component C3 in Protection Against
Sahu SK; Maurya RK; Kulkarni HS
DNA Cell Biol; 2024 Apr; 43(4):153-157. PubMed ID: 38324102
[TBL] [Abstract][Full Text] [Related]
2. Lung epithelial cell-derived C3 protects against pneumonia-induced lung injury.
Sahu SK; Ozantürk AN; Kulkarni DH; Ma L; Barve RA; Dannull L; Lu A; Starick M; McPhatter J; Garnica L; Sanfillipo-Burchman M; Kunen J; Wu X; Gelman AE; Brody SL; Atkinson JP; Kulkarni HS
Sci Immunol; 2023 Feb; 8(80):eabp9547. PubMed ID: 36735773
[TBL] [Abstract][Full Text] [Related]
3. The alternative activation pathway and complement component C3 are critical for a protective immune response against Pseudomonas aeruginosa in a murine model of pneumonia.
Mueller-Ortiz SL; Drouin SM; Wetsel RA
Infect Immun; 2004 May; 72(5):2899-906. PubMed ID: 15102802
[TBL] [Abstract][Full Text] [Related]
4. A new role of the complement system: C3 provides protection in a mouse model of lung infection with intracellular Chlamydia psittaci.
Bode J; Dutow P; Sommer K; Janik K; Glage S; Tümmler B; Munder A; Laudeley R; Sachse KW; Klos A
PLoS One; 2012; 7(11):e50327. PubMed ID: 23189195
[TBL] [Abstract][Full Text] [Related]
5. Intracellular C3 Protects Human Airway Epithelial Cells from Stress-associated Cell Death.
Kulkarni HS; Elvington ML; Perng YC; Liszewski MK; Byers DE; Farkouh C; Yusen RD; Lenschow DJ; Brody SL; Atkinson JP
Am J Respir Cell Mol Biol; 2019 Feb; 60(2):144-157. PubMed ID: 30156437
[TBL] [Abstract][Full Text] [Related]
6. Murine complement interactions with Pseudomonas aeruginosa and their consequences during pneumonia.
Younger JG; Shankar-Sinha S; Mickiewicz M; Brinkman AS; Valencia GA; Sarma JV; Younkin EM; Standiford TJ; Zetoune FS; Ward PA
Am J Respir Cell Mol Biol; 2003 Oct; 29(4):432-8. PubMed ID: 14500254
[TBL] [Abstract][Full Text] [Related]
7. Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis.
Gralinski LE; Sheahan TP; Morrison TE; Menachery VD; Jensen K; Leist SR; Whitmore A; Heise MT; Baric RS
mBio; 2018 Oct; 9(5):. PubMed ID: 30301856
[TBL] [Abstract][Full Text] [Related]
8. Activation of cannabinoid-2 receptor protects against Pseudomonas aeruginosa induced acute lung injury and inflammation.
Nagre N; Nicholson G; Cong X; Lockett J; Pearson AC; Chan V; Kim WK; Vinod KY; Catravas JD
Respir Res; 2022 Dec; 23(1):326. PubMed ID: 36463179
[TBL] [Abstract][Full Text] [Related]
9. Cytokine regulation of C3 and C5 production by the human type II pneumocyte cell line, A549.
Rothman BL; Despins AW; Kreutzer DL
J Immunol; 1990 Jul; 145(2):592-8. PubMed ID: 2114444
[TBL] [Abstract][Full Text] [Related]
10. Complement inhibition alleviates paraquat-induced acute lung injury.
Sun S; Wang H; Zhao G; An Y; Guo Y; Du L; Song H; Qiao F; Yu H; Wu X; Atkinson C; Jiang S; Tomlinson S; Zhou Y
Am J Respir Cell Mol Biol; 2011 Oct; 45(4):834-42. PubMed ID: 21421909
[TBL] [Abstract][Full Text] [Related]
11. Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination.
Kim YJ; Kim KH; Ko EJ; Kim MC; Lee YN; Jung YJ; Lee YT; Kwon YM; Song JM; Kang SM
J Virol; 2018 Oct; 92(20):. PubMed ID: 30068650
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways.
Strunk RC; Eidlen DM; Mason RJ
J Clin Invest; 1988 May; 81(5):1419-26. PubMed ID: 2966814
[TBL] [Abstract][Full Text] [Related]
13. Bbeta(15-42) protects against acid-induced acute lung injury and secondary pseudomonas pneumonia in vivo.
Matt U; Warszawska JM; Bauer M; Dietl W; Mesteri I; Doninger B; Haslinger I; Schabbauer G; Perkmann T; Binder CJ; Reingruber S; Petzelbauer P; Knapp S
Am J Respir Crit Care Med; 2009 Dec; 180(12):1208-17. PubMed ID: 19762562
[TBL] [Abstract][Full Text] [Related]
14. Silica induced suppression of the production of third and fifth components of the complement system by human lung cells in vitro.
Rothman BL; Contrino J; Merrow M; Despins A; Kennedy T; Kreutzer DL
Immunopharmacol Immunotoxicol; 1994 Nov; 16(4):525-51. PubMed ID: 7876460
[TBL] [Abstract][Full Text] [Related]
15. Effect of interleukin-4 on the synthesis of the third component of complement by pulmonary epithelial cells.
Christian-Ritter KK; Hill LD; Hoie EB; Zach TL
Am J Pathol; 1994 Jan; 144(1):171-6. PubMed ID: 8291606
[TBL] [Abstract][Full Text] [Related]
16. Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3.
Kerr AR; Paterson GK; Riboldi-Tunnicliffe A; Mitchell TJ
Infect Immun; 2005 Jul; 73(7):4245-52. PubMed ID: 15972516
[TBL] [Abstract][Full Text] [Related]
17. Role of C3, C5 and anaphylatoxin receptors in acute lung injury and in sepsis.
Bosmann M; Ward PA
Adv Exp Med Biol; 2012; 946():147-59. PubMed ID: 21948367
[TBL] [Abstract][Full Text] [Related]
18. Serum amyloid A3 confers protection against acute lung injury in
Fan Y; Zhang G; Vong CT; Ye RD
Am J Physiol Lung Cell Mol Physiol; 2020 Feb; 318(2):L314-L322. PubMed ID: 31851532
[No Abstract] [Full Text] [Related]
19. Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin.
Russkamp NF; Ruemmler R; Roewe J; Moore BB; Ward PA; Bosmann M
FASEB J; 2015 Sep; 29(9):3762-72. PubMed ID: 25999468
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]